Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids

摘要

Nanoparticulate crystalline drug substances formulated in an aqueos phase emulsified in oil, are able to be made at less than 1000 nm size and provide increased bioavailability and lymphatic uptake following oral administration.